The arachidnate metabolism in alveolar macrophages (AM) was investigated in human AM. The AM was obtained by bronchoalveolar lavage (BAL) from normal volunteers (NV group) and from patients with a localized pulmonary disease (control patients, CP group). In the CP group, BAL was performed in the lung contralateral to that with the lesion. The NV group consisted of nonsmokers and smokers, and the CP group consisted only of smokers.
I Uptake of radiolobelled arachidonic acid by AM
In vitro uptake of
14C-arachidonic acid by AM from smokers was not significantly different from that from nonsmokers, in the NV group.
The pattern of incorporation of
14C-arachidonic acid into phospholipid and neutral lipid fraction of AM from smokers was also not significantly different from that from nonsmokers.
II In vitro release of arachidonate metabolites by zymosan-stimulated AM
The amount of thromboxane A
2 (TX A
2) released by AM was evaluated by two methods. In method I, the amount to TX B
2 (stable from of TX A
2) released was directly measured by radioimmunoassay. In method II, AM was prelabelled with
14C-arachidonic acid, and the amount of TX B
2 released was judged by the percentage of radioactivity in the TX B
2 from incubation medium comparison to total uptake by AM. There was a significant correlation between the value by methods I and II. Therefore the amounts of other arachidnate metabolites released was judged by the method II.
The amount of prostaglandin E
2 and a lipoxygenase product, as well as TX B
2 released by 10
6 of AM, was decreased in the AM from smokers compared with that from nonsmokers, in the NV group.
The number of AM obtained by BAL was larger in the smokers of both the NV and CP groups than in the nonsmokers of the NV group. When the amount of TX B
2 released from 10
6 of AM was measured by method I, it was also decreased in the AM from smokers of both groups compared with that from nonsmokers of the NV group. However, the amount of TX B
2 released by total AM obtained by BAL tended to be larger in smokers than in nonsmokers.
These results indicate that release of arachidnate metabolite of AM in response to a stimulus may be decreased in smokers compared with nonsmokers. It was also suggested that the number as well as function of AM must be kept in mind when physiological and pathophysiological roles of arachidnate metabolite released by AM are considered.
View full abstract